Provision Announces New “Supersized” 3D Holographic Product
Oct 10, 2016 11:30 am UTC| Business
CHATSWORTH, Calif., Oct. 10, 2016 -- Provision Interactive Technologies, Inc. ("Provision"), a subsidiary of Provision Holding, Inc. (OTCQB:PVHO), announced today that it has completed the development and prototype of...
Oct 10, 2016 11:21 am UTC| Business
Dublin, Oct. 10, 2016 -- Research and Markets has announced the addition of the "Global Market Report On Grepafloxacin Hydrochloride 2016" report to their offering. The Global...
Oct 10, 2016 11:10 am UTC| Business
SEATTLE, Oct. 10, 2016 -- Cascadian Therapeutics (NASDAQ:CASC), a clinical-stage biopharmaceutical company, today announced the presentation of clinical activity of tucatinib, its investigational, highly selective small...
Oct 10, 2016 11:05 am UTC| Business
SAN RAMON, Calif., Oct. 10, 2016 -- Galena Biopharma, Inc. (NASDAQ:GALE), a biopharmaceutical company committed to the development and commercialization of hematology and oncology therapeutics that address unmet medical...
Oct 10, 2016 11:00 am UTC| Business
BOSTON, Oct. 10, 2016 -- ZIOPHARM Oncology, Inc. (Nasdaq:ZIOP) announced the presentation of preliminary data from the Company’s Phase 1b/2 study of Ad-RTS-hIL-12 + veledimex following standard chemotherapy for the...
Nova LifeStyle Announces Leadership Change
Oct 10, 2016 11:00 am UTC| Business
LOS ANGELES, Oct. 10, 2016 -- Nova LifeStyle, Inc. (NASDAQ:NVFY) (“Nova LifeStyle” or the “Company”), a U.S.-based, leading innovative designer, manufacturer and distributor of modern life style furniture, today...
Oct 10, 2016 11:00 am UTC| Business
Phase 2 Results in the Treatment of Macular Edema Associated with Retinal Vein Occlusion Phase 2 and Phase 1/2 Results in the Treatment of Macular Edema Associated with Non-Infectious Uveitis ALPHARETTA, Ga., Oct. 10,...